Women 3.5 Times More Likely to Develop Heart Disease or Die Suddenly After AstraZeneca COVID Vaccine
A new report shows that women aged 12-29 who received AstraZeneca/Oxford University’s Vaxzevria adenovirus vectored COVID-19 vaccine are three and a half times more likely to develop heart disease, suffer sudden death, or both, in the 12 days post vaccination.1 The statistical model linked 11 out of 15 cardiac deaths directly to Vaxzevria, also citing […]
Psychotic Disorders Reported After mRNA COVID Shots
Nearly two years after the global distribution of messenger RNA (mRNA) COVID-19 shots, it is now known that these biologics cause mild side effects that include pain at the injection site, fever, fatigue, headache, muscle pain, chills, and diarrhea, and they also can cause severe adverse effects such as anaphylaxis, heart inflammation (myocarditis/pericarditis), thrombosis (blood […]
Canadian Woman Dies Seven Minutes After Getting COVID Booster
A sixty-nine-year-old woman died on Sept. 14, 2022 in Saskatoon (Saskatchewan), Canada seven minutes after getting a booster dose of a COVID shot at a Shoppers Drug Mart. Carol Diane Pierce, who was reportedly healthy, received the booster and was waiting during the required 15-minute period of observation before leaving the drugstore when she suddenly […]
Study Reveals Much Higher Risk for Serious Adverse Events With mRNA COVID Shots in Clinical Trials
A new study published in the journal Vaccine revealed there was a much higher risk of serious adverse events of special interest for randomized clinical trial participants who received a messenger RNA (mRNA) COVID-19 biologic when compared to participants, who received a placebo for both the Pfizer/BioNTech mRNA BNT162b2 (also known as “Comirnaty”) COVID shot […]
FDA Panel Recommends EUA for Novavax COVID-19 Vaccine
Despite concerns about the risk of developing myocarditis (inflammation of the heart muscle) and pericarditis (inflammation of the lining of the heart) following vaccination with Novavax’s experimental NVX-CoV2373 (also known as “Nuvaxovid” and “Covovax”) COVID-19 vaccine, the U.S. Food and Drug Administration’s (FDA) Vaccines and Related Biological Products Advisory Committee (VRBPAC) voted on June 6, […]
FDA Flags Risk of Myocarditis in Novavax COVID Vaccine
Novavax, one of the worst performers on Wall Street, and that is after an FDA warning on its COVID vaccine. Year to date, down 68 percent. Of course, that coming as a result of the FDA out with their analysis from Novavax’s data that they submitted for the emergency use filing for the meeting coming […]
